Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
122 hedge funds and large institutions have $832M invested in Intersect ENT, Inc in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 21 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
17% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 35
3% more capital invested
Capital invested by funds: $807M → $832M (+$24.9M)
0% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 21
1% less funds holding
Funds holding: 123 → 122 (-1)
86% less call options, than puts
Call options by funds: $131K | Put options by funds: $911K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLCMU
Kite Lake Capital Management (UK)
London,
United Kingdom
|
+$35.8M |
| 2 |
VI
Versor Investments
New York
|
+$24.9M |
| 3 |
MAM
Melqart Asset Management
London,
United Kingdom
|
+$16.7M |
| 4 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$11.6M |
| 5 |
N
Natixis
Paris,
France
|
+$9.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$39.6M |
| 2 |
Neuberger Berman Group
New York
|
-$16.1M |
| 3 |
Millennium Management
New York
|
-$15.4M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$11.9M |
| 5 |
Two Sigma Advisers
New York
|
-$9.16M |
XENT Hedge Fund Activity: Q4 2021 in Review
122 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2021, worth a combined $832M — up 3.1% from $807M a quarter earlier.
Fund positioning in XENT was balanced in Q4 2021: 21 funds opened new positions, 21 closed out, 41 added to existing stakes and 35 trimmed.
The largest buyer was Kite Lake Capital Management (UK), opening a new position worth an estimated $35.8M. The largest seller was Artisan Partners, exiting entirely with an estimated $39.6M sold.
- 122 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2021, down from 123 in Q3 2021.
- Funds reported $832M of Intersect ENT, Inc stock for Q4 2021, up 3.1% quarter-over-quarter.
- 21 funds opened new Intersect ENT, Inc positions in Q4 2021 and 21 closed out, a net change of 0 holders.
- The largest Intersect ENT, Inc buyer in Q4 2021 was Kite Lake Capital Management (UK), an estimated $35.8M added.
- The largest Intersect ENT, Inc seller in Q4 2021 was Artisan Partners, an estimated $39.6M sold.
Based on aggregated 13F filings for Q4 2021.